Abstract
Purpose of Review
Cardiac sarcoidosis (CS) is associated with significant morbidity and mortality. The diagnosis of CS is challenging and typically one that is only entertained after many other conditions have been ruled out. A high index of suspicion is necessary in order to correctly determine appropriate testing for the disease. Transthoracic echocardiography is the most readily available imaging modality available to help establish a diagnosis in a potential patient. However, no one echocardiographic feature is pathognomonic.
Recent Findings
On echocardiography, unusual wall motion abnormalities, which do not fit a classic coronary distribution, along with diastolic dysfunction may alert one to the presence of cardiac sarcoid, particularly in the right clinical context. Myocardial strain imaging on echocardiography may increase the sensitivity of identifying cardiac sarcoidosis. Alternative imaging with cardiac magnetic resonance imaging or positron emission tomography have become more frequently utilized to establish a diagnosis of CS.
Summary
Cardiac sarcoidosis remains a difficult condition to diagnose. However early diagnosis is critical to decrease the associated high mortality. Endomyocardial biopsy is highly specific but lacks sensitivity due to the patchy nature of the granulomatous deposition. Thus, imaging plays a role in diagnosis as well as for follow-up. Echocardiography remains an hallmark during the workup for CS. Decreased sensitivity of echocardiography has facilitated the use of other techniques to establish the presence of CS.
Similar content being viewed by others
Abbreviations
- AV:
-
Atrioventricular
- CMR:
-
Cardiac magnetic resonance
- CS:
-
Cardiac sarcoidosis
- CV:
-
Cardiovascular
- EKG:
-
Electrocardiogram
- EMB:
-
Endomyocardial biopsy
- GLS:
-
Global longitudinal strain
- LV:
-
Left ventricle/left ventricular
- PET/CT:
-
18F-fleurodeoxyglucose positron emission tomography/computed tomography
- PHT:
-
Pulmonary hypertension
- RV:
-
Right ventricle/right ventricular
- TR:
-
Tricuspid regurgitation
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major Importance
Boeck C. Multiple benign sarcoid of the skin. J Cutan Genitourin Dis. 1899;17:543–50.
Johnson JB, Jason RS. Sarcoidosis of the heart. Am Heart J. 1944;27(2):246–58.
Longcope WT, Freiman DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine. 1952;31(1):1–132.
Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015;147(2):438–49.
Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–23.
Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P-Y, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155–67.
Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119(2):167–72.
Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204–11.
Blauwet LA, Cooper LT. Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev. 2013;18(6):733–46.
Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, et al. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9–21.
Yigla M, Badarna-Abu-Ria N, Tov N, Ravell-Weiller D, Rubin AH. Sarcoidosis in northern Israel; clinical characteristics of 120 patients. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(3):220–6.
Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest. 1993;103(1):253–8.
Zipse MM, Sauer WH. Cardiac sarcoidosis. Curr Cardiol Rep. 2014;16(8):514.
Mantini N, Williams B Jr, Stewart J, Rubinsztain L, Kacharava A. Cardiac sarcoid: a clinician’s review on how to approach the patient with cardiac sarcoid. Clin Cardiol. 2012;35(7):410–5.
Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68(4):411–21.
•• Murtagh G, Laffin LJ, Beshai JF, Maffessanti F, Bonham CA, Patel AV, et al. Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2016;9(1):e003738 This study highlights the use of cardiac MR to help identify patients with increased cardiovascular morbidity whose echocardiogram is otherwise unremarkable.
Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2012;23(9):925–9.
Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti VR, et al. Isolated cardiac sarcoidosis: a focused review of an under-recognized entity. J Nucl Cardiol 2018;25(4):1136–46. https://doi.org/10.1007/s12350-016-0658-1
Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016;6(1):50–63.
Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J. 2005;150(3):459–63.
•• Riemer HJA, Slart AJMG, Patrizio Lancellotti FH, Blankstein R, Schwartz RG, Jaber RR WA, et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Eur Heart J Cardiovasc Imaging. 2017;18(10):1073–89 An important position paper illustrating the need for multi-modality imaging to detect the presence of cardiac sarcoidosis.
Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008;133(6):1426–35.
Youssef G, Beanlands RS, Birnie DH, Nery PB. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart. 2011;97(24):2078–87.
Bargout R, Kelly RF. Sarcoid heart disease: clinical course and treatment. Int J Cardiol. 2004;97(2):173–82.
•• Aggarwal NR, Snipelisky D, Young PM, Gersh BJ, Cooper LT, Chareonthaitawee P. Advances in imaging for diagnosis and management of cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. 2015;16(9):949–58 Excellent review outlining the approach in the clinical setting to assess for cardiac involvement in sarcoidosis, utilizing multiple diagnostic tools.
Focardi M, Picchi A, Nikiforakis N, Bargagli E, Fossi A, Maggiorelli C, et al. Assessment of cardiac involvement in sarcoidosis by echocardiography. Rheumatol Int. 2009;29(9):1051–5.
Smedema J‐P, van Geuns R‐J, Ainslie G, Ector J, Heidbuchel H, Crijns HJGM. Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance. ESC Heart Fail. 2017;4(4):535–44.
Patel MB, Mor-Avi V, Murtagh G, Bonham CA, Laffin LJ, Hogarth DK, et al. Right heart involvement in patients with sarcoidosis. Echocardiography. 2016;33(5):734–41.
Huitema MP, Grutters JC, Rensing BJWM, Reesink HJ, Post MC. Pulmonary hypertension complicating pulmonary sarcoidosis. Neth Hear J. 2016;24(6):390–9.
Baughman RP, Engel PJ, Taylor L, Lower EE. Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest. 2010;138(5):1078–85.
Zelcer AA, LeJemtel TH, Jones J, Stahl J. Pericardial tamponade in sarcoidosis. Can J Cardiol. 1987;3(1):12–3.
Darda S, Zughaib ME, Alexander PB, Machado CE, David SW, Saba S. Cardiac sarcoidosis presenting as constrictive pericarditis. Tex Heart Inst J. 2014;41(3):319–23.
Lynch JP, Hwang J, Bradfield J, Fishbein M, Shivkumar K, Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med. 2014;35(3):372–90.
Zoneraich S, Gupta MP, Mehta J, Zoneraich O, Wessely Z. Myocardial sarcoidosis presenting as acute mitral insufficiency. Chest. 1974;66(4):452–4.
Murtagh G, Laffin LJ, Patel KV, Patel AV, Bonham CA, Yu Z, et al. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography. 2016;33(9):1344–52.
Felekos I, Aggeli C, Gialafos E, Kouranos V, Rapti A, Sfikakis P, et al. Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease. Echocardiography. 2018;35(6):804–8. https://doi.org/10.1111/echo.13846.
Joyce E, Ninaber MK, Katsanos S, Debonnaire P, Kamperidis V, Bax JJ, et al. Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail. 2015;17(1):51–62.
Joyce E, Delgado V, Ninaber MK, Marsan NA. The invisible made visible: multi-modality imaging in the evaluation of cardiac sarcoidosis. Eur Heart J. 2013;34(17):1278.
Joyce E, Kamperidis V, Ninaber MK, Katsanos S, Debonnaire P, Schalij MJ, et al. Prevalence and correlates of early right ventricular dysfunction in sarcoidosis and its association with outcome. J Am Soc Echocardiogr. 2016;29(9):871–8.
Greulich S, Kitterer D, Kurmann R, Henes J, Latus J, Gloekler S, et al. Cardiac involvement in patients with rheumatic disorders: data of the RHEU-M(A)R study. Int J Cardiol. 2016;224:37–49.
• Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58(8):1341–53 Paper focusing on the newest technique for the detection of cardiac sarcoid: PET imaging with a highly specific protocol to detect CS.
Wicks EC, Menezes LJ, Elliott PM. Improving the diagnostic accuracy for detecting cardiac sarcoidosis. Expert Rev Cardiovasc Ther. 2015;13(2):223–36.
Costabel U, Skowasch D, Pabst S, Stork S, Tschope C, Allewelt M, et al. Cardiac sarcoidosis: diagnostic and therapeutic algorithms. Pneumologie. 2014;68(2):124–32.
Funding
Dr. Kurmann has received funding from the Department of Rheumatology and Clinical Immunology, University of Bern, Bern, Switzerland.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Reto Kurmann, Sunil V. Mankad, and Rekha Mankad declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Echocardiography
Rights and permissions
About this article
Cite this article
Kurmann, R., Mankad, S.V. & Mankad, R. Echocardiography in Sarcoidosis. Curr Cardiol Rep 20, 118 (2018). https://doi.org/10.1007/s11886-018-1065-9
Published:
DOI: https://doi.org/10.1007/s11886-018-1065-9